Neuroendocrine Tumors
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Post-Authorization Long-Term Safety Study of LUTATHERA
Update on the post-authorization long-term safety study of LUTATHERA for neuroendocrine tumors, with study status listed as ACTIVE_NOT_RECRU…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers [Phase 1]
This clinical trial update describes a Phase 1 study evaluating the tolerability of BI 764532 in combination with chemotherapy in patients w…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors [NA]
Clinical trial update on Lu-DOTATATE treatment for somatostatin receptor–positive neuroendocrine tumors; the study is currently active but n…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Evaluation of Tolerance and Quality of Life in Patients With Neuroendocrine Tumors Treated With Oral Anti-Tumor Drugs Within a Therapeutic Education Program
A clinical trial protocol evaluating tolerance and quality of life in neuroendocrine tumors patients treated with oral anti-tumor drugs with…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Lutathera and ASTX727 in Neuroendocrine Tumours [Phase 1]
Imperial College London is conducting a Phase 1 study evaluating Lutathera in combination with ASTX727 for neuroendocrine tumors, currently …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents [NA]
A completed clinical trial evaluating MGMT enzyme status as a predictive factor for response to alkylating agents in neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors [Phase 2]
A Phase 2 clinical trial comparing lesion-to-lesion imaging using 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT for evaluating metastatic n…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer [Phase 1]
Phase 1 study to evaluate how the investigational cancer drug BI 764532 is taken up by tumors in people with small cell lung cancer or neuro…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Imaging of Solid Tumors Using DLL3 SPECT [EARLY_Phase 1]
Early Phase 1 clinical trial evaluating DLL3 SPECT imaging for solid tumors, including castration-resistant prostate cancer and neuroendocri…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
University of Chicago is recruiting for a tissue procurement study across multiple cancers in patients undergoing surgery or biopsy to colle…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: EchoTip AcuCore Post-Market Clinical Study
Completed post-market clinical study update for the EchoTip AcuCore device, detailing the completion of the post-market evaluation.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-M14D1 in locally advanced or metastatic small cell lung cancer, neuroendocrine tumors, and other solid …
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Open-label Study of Surufatinib in Japanese Patients [Phase 1, Phase 2]
Open-label Phase 1/Phase 2 study of Surufatinib in Japanese patients with Neuroendocrine Tumors has completed.
-
EMA approval · 2025-09-15EMA Authorised: Locametz (gozetotide) — Novartis Europharm Limited
EMA authorised Locametz (gozetotide) for radionuclide imaging, with Novartis Europharm Limited as the marketing authorisation holder; decisi…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies [Phase 1]
Ongoing Phase 1 safety/efficacy trial of CID-078 in patients with advanced/metastatic solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072 [NA]
A long-term safety surveillance study of participants previously treated with 177Lu-IPN01072 has been completed, monitoring safety outcomes …
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms
A clinical trial is investigating acquired resistance to alkylator chemotherapy in neuroendocrine tumors and endocrine cancers and is curren…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs [Phase 3]
Phase 3 trial evaluating diagnostic efficacy, pharmacokinetics, and safety of 68Ga-DOTATATE PET/CT for detecting neuroendocrine tumors; curr…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors [EARLY_Phase 1]
An EARLY Phase 1 clinical trial of Gallium-68 Pentixafor for neuroendocrine tumors is listed as active but not currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs [Phase 3]
A Phase III trial comparing 177Lu-DOTATATE injections to long-acting Oxytrexine in adults with neuroendocrine tumors, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers [Phase 2]
Phase 2 study evaluating adoptive transfer of tumor-infiltrating lymphocytes (TIL) for advanced solid cancers, with multiple site-specific i…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors
This document reports the completion of a clinical trial evaluating whole-body dynamic PET/CT imaging with 68Ga-DOTATOC in neuroendocrine tu…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients [Phase 2]
Phase 2 trial comparing 177Lu-Dotatate with capecitabine vs 177Lu-Dotatate alone in neuroendocrine tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery [NA]
An update on a clinical trial comparing endhole versus pressure-modulated Lipiodol delivery for hepatocellular carcinoma and neuroendocrine …
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use [Phase 1, Phase 2]
An imaging study using [68]Ga-HA-DOTATATE to identify/diagnose tumors with somatostatin receptors is being evaluated for safety and diagnost…